News

Institutional visit of the Catalan Minister for Research and Universities to IGTP to learn about its research and innovation projects in health

This morning, Núria Montserrat, Catalan Minister for Research and Universities, visited the Comparative Medicine and Bioimaging Centre of Catalonia (CMCiB), a leading infrastructure of the Germans Trias i Pujol Research Institute (IGTP). The aim of the visit was to gain first-hand insight into the scientific and technological projects carried out in fields such as bioimaging, experimental surgery, and the validation of new medical devices and therapies. Additionally, the visit provided an opportunity to further explore IGTP's impact on translational research and its contribution to health innovation.

During the meeting, the Minister met with IGTP's General Director, Jordi Barretina; Scientific Director, Julia García-Prado; IGTP's Manager, Carles Esquerré; the Manager of the Germans Trias i Pujol Hospital, Josep Mª Mòdol; the Clinical Director of Nephrology and Clinical Research Coordinator, Jordi Ara; the Head of the Innovation and Transfer Unit, Raül Zurita; Càrol Gálvez-Montón, CERTERA-IGTP coordinator, and the Head of General Services at IGTP, Francesc Velarde. Also present were Victoria Delgado, Scientific Director of the CMCiB, Sara Capdevila, technical director, and Míriam Gironès, Business Development Director of the centre.

The visit highlighted the centre's role as a reference infrastructure driving preclinical research, healthcare innovation, and knowledge transfer. Furthermore, the CMCiB is a leading centre in robotic surgery training, contributing to the advancement of cutting-edge surgical techniques.

The Minister's visit reaffirms the commitment of the Department for Research and Universities to fostering scientific innovation and supporting strategic infrastructures that drive progress in Catalonia's research and healthcare system.


The CMCiB at IGTP is a leading preclinical research centre in Catalonia, dedicated to translational medicine and biomedical innovation. Equipped with state-of-the-art facilities, it facilitates the use of experimental models and advanced bioimaging technologies, promoting knowledge transfer and collaboration with hospitals, universities, and companies. It also plays a key role in validating new medical devices, supporting their clinical application and commercialisation.

 

More news